(redirected from Urge Urinary Incontinence)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia.
Related to Urge Urinary Incontinence: stress urinary incontinence
References in periodicals archive ?
The difference of Qmax, daytime urination frequency, night urination frequency, urge urinary incontinence and urgent urination before and after treatment in the observation group was significantly different with that in the control group (P0.
What predicts and what mediates the response of urge urinary incontinence to biofeedback?
In this connection the purpose of this study was to assess efficacy of various modes of medicamentous therapy concluded in monotherapy with M-cholinolytics and combined therapy of M-cholinolytics with al-adrenoblockers in the urge urinary incontinence.
org) recruited patients with refractory urge urinary incontinence and urodynamic evidence of detrusor overactivity incontinence (DOI) to a 2:1 placebo controlled cystoscopic injection of botulinum toxin A.
This finding suggests that depressed patients have more symptoms and a greater impact on their lives from urge urinary incontinence, Dr.
HCFA also said that pelvic floor stimulators inserted into the vaginal canal or the rectum would be covered as reasonable and necessary for the treatment of stress and urge urinary incontinence.
The primary endpoint was change in mean number of urge urinary incontinence episodes per 24 hours from baseline to week 12.
The application seeks approval for mirabegron for use in combination with solifenacin succinate 5 mg for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency.
Not only is the biofeedback (BFB)-assisted pelvic floor muscle training treatment for urge urinary incontinence (UUI) effective according to the current study (Riley & Organist, 2014), it may prove to be long lasting in its effectiveness.
Exclusion criteria included previous anti-incontinence surgery, post-void residual bladder volume >100 mL, urinary incontinence requiring >5 pads per day, previous pelvic irradiation/cryotherapy or clinical urge urinary incontinence.
Astellas Pharma developed the drug for the treatment of OAB with symptoms of urge urinary incontinence, urgency, and urinary frequency.
3) A population-based study in the United States suggested an even higher rate of urinary incontinence here: greater than 50% in women 60 years or older, with 1) urge urinary incontinence (UUI) predominating (4) and 2) the prevalence particularly high among older women who are homebound or who live in a long-term care facility.